BDR Pharmaceuticals, a Mumbai-based active pharmaceutical ingredient (API) manufacturing company, has developed the API of antiviral pill Paxlovid and can manufacture the drug but it has decided to wait and watch, Shah said. “We will see if there is any need in the country to launch it,” he told ET. “At present, cases are mild and are recovering with the conventional treatment.”
